Alexandr V Mukhomedzyanov

12PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsHaematological tumoursCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 07, 2025
Metabolic syndrome reduces but does not eliminate the cardioprotective effect of adaptation to hypoxia: the link with changes in the opioid system.

Natalia V Naryzhnaya, Ivan A Derkachev, Boris K Kurbatov

|Jun 27, 2024
The Nephroprotective Effect of Nitric Oxide during Extracorporeal Circulation: An Experimental Study.

Nikolay O Kamenshchikov, Yuri K Podoksenov, Boris N Kozlov

|May 11, 2024
Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists.

Alla A Boshchenko, Leonid N Maslov, Alexander V Mukhomedzyanov

|Apr 27, 2024
Potential Mechanisms for Organoprotective Effects of Exogenous Nitric Oxide in an Experimental Study.

Nikolay O Kamenshchikov, Mariia L Diakova, Yuri K Podoksenov

|Feb 04, 2024
Angiotensin 1-7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart-The signaling mechanism.

Ivan A Derkachev, Sergey V Popov, Leonid N Maslov

|Jan 23, 2024
Ferroptosis, a Regulated Form of Cell Death, as a Target for the Development of Novel Drugs Preventing Ischemia/Reperfusion of Cardiac Injury, Cardiomyopathy and Stress-Induced Cardiac Injury.

Vyacheslav V Ryabov, Leonid N Maslov, Evgeniy V Vyshlov

Pageof 2

Frequent Collaborators

12 joint publications

Leonid N Maslov

6 joint publications

Natalia V Naryzhnaya

5 joint publications

Alla A Boshchenko

4 joint publications

Boris K Kurbatov